Legal & General Group’s Renalytix plc American Depositary Shares RNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-19,279
Closed -$133K 3693
2022
Q1
$133K Hold
19,279
﹤0.01% 2800
2021
Q4
$307K Buy
+19,279
New +$386K ﹤0.01% 2565

Other funds holding RNLX

Legal & General Group's RNLX Position: Q2 2022 in Review

Legal & General Group sold out of Renalytix plc American Depositary Shares (RNLX) in Q2 2022, closing a stake of 19,279 shares — an estimated $133K sold.

Legal & General Group first reported a position in RNLX in Q4 2021 and held it in 2 quarters. The position peaked at $307K in Q4 2021. 31 funds tracked by Wall St. Rank hold RNLX as of Q2 2022.

  • Legal & General Group reported no remaining Renalytix plc American Depositary Shares position as of Q2 2022 after selling out during the quarter.
  • Legal & General Group sold 19,279 Renalytix plc American Depositary Shares shares in Q2 2022, an estimated $133K.
  • Legal & General Group first reported a position in Renalytix plc American Depositary Shares in Q4 2021 and held it in 2 quarters.
  • Legal & General Group's Renalytix plc American Depositary Shares position peaked at $307K in Q4 2021.
  • 31 funds tracked by Wall St. Rank held Renalytix plc American Depositary Shares as of Q2 2022.

Based on Legal & General Group's 13F filing for Q2 2022, filed 22 Aug 2022.